BL-1021

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameBL-1021
Drug Alias NameNortriptyline-GABAAN-228BL-1021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBar Ilan UniversityRamot At Tel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A